We are currently enrolling a weight loss study evaluating the safety, tolerability and effectiveness of a GLP-1 and GIP medication. If you participate in the trial, your participation will last approximately 84 weeks with 15 visits to our office, and 7 virtual visits. Compensation may be available for those who qualify.
Obesity has been steadily increasing across the US and around the world for more than four decades. Beyond affecting daily life, it can also lead to serious health problems such as:
You may qualify if you meet the following requirements:
If you are ready to learn more or find out if you qualify, please fill out the form below to get started.
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
Rochester Clinical Research is seeking adults to participate in a research study evaluating an investigational medication for nerve pain caused […]
Adults 65 years and older may qualify for a study evaluating an investigational vaccine designed to help prevent C. difficile […]
Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling […]
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome […]
